Sajjad Mueed, MD

Director, Memorial Medical Center Stroke Center, Neurologist

Neurology

Accepting new patients

Call for an appointment

217-545-8000

I am a:

Request appointment

Languages:

English, Urdu

About me

Dr. Mueed, is an Associate Professor in the Department of Neurology at SIU School of Medicine and SIU Medicine. Dr. Mueed is the Director of the Comprehensive Stroke Center at Memorial Medical Center. Dr. Mueed is a neurologist who specializes in stroke, electrodiagnosis and sleep, and neurorehabilitation. Dr. Mueed is board certified in American Board of Psychiatry and Neurology (Neurology), American Board of Psychiatry and Neurology (Clin. Neurophys.), American Board of Sleep Medicine, American Board of Psychiatry and Neurology (Vascular Neurology), American Board of Electrodiagnostic Medicine, American Board of Psychiatry and Neurology (Sleep Medicine), United Council for Neurologic Subspecialties (UCNS) Certified in Neuroimaging, United Council for Neurologic Subspecialties (UCNS) Certified in Neural Repair and Rehabilitation.

Gender

Male

Additional languages spoken

Urdu

Education & training

Positions

Associate Professor

Department of Neurology

Director, Comprehensive Stroke Center at Memorial Medical

Board Certifications

Neurology

Neural Repair and Rehabilitation

Neuroimaging

Internal Medicine

Sleep Medicine

Clinical Neurophysiology

Vascular Neurology

Electrodiagnostic Medicine

Medical School

Quaid-e-Azam Medical College in Bahawalpur, Pakistan

Residency

SIU School of Medicine, Springfield, IL - Neurology

Fellowship

SIU School of Medicine, Springfield, IL - Epilepsy & Clinical Neurophysiology and Stroke

Specialties

Neurology

Treatments & procedures

Appointments

SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community.

Request an appointment

Clinical locations

Locations

SIU Neurology Clinic

751 N. Rutledge St. Springfield, IL 62702 Suite 3100

Get Directions

Mon - Fri: 8:00 am-4:30 pm

Hospital privileges

Abraham Lincoln Memorial Hospital, Lincoln IL
HSHS St. John's Hospital, Springfield, IL
Memorial Health, Springfield IL

Research

Research Interests

Stroke Specialist, Sleep Disorders, Vascular Neurology, Electro diagnostic Medicine, and Clinical Neurophysiological Studies.

Clinical trials

Trial

Neuroscience Institute

Sleep for Stroke Management and Recovery Trial

Active recruiting

The primary goals of this study are to determine whether treatment of obstructive sleep apnea with positive airway pressure starting shortly after accute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event and (2) improves stroke outcomes at 3 months in patients who experienced ischemic stroke.

Trial

Neuroscience Institute

18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

Active not recruiting

18-513: The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

Trial

Neurology

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Active recruiting

The primary objective is to assess the effect of XEN1101 versus placebo on reducing PGTCS frequency in subjects with PGTCS.

Trial

Neurology

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Active recruiting

The primary objective of this study is to assess the effect of XEN1101 versus placebo on reducing focal seizure frequency.

Trial

Neurology

An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Active recruiting

The primary endpoint of this study is to evaluate the long-term safety and tolerability of Staccato alprazolam.

Trial

Neurology

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Active recruiting

The purpose of this study is to compare the success of a single admnistration of Staccato alprazolam compared with placebo in rapidly terminating a seizure episode within 90seconds after IMP administration.